Keyword Connections

cdk

Journals

1

1 Future medicinal chemistry

Research Groups

0

No Research Group Connected

Bibliographies

41

1 Synthesis and anticancer activity of some pyrido[2,3-]pyrimidine derivatives as apoptosis inducers and cyclin-dependent kinase inhibitors.

2 The PI3K/AKT/mTOR and CDK4/6 pathways in endocrine resistant HR+/HER2- metastatic breast cancer: Biological mechanisms and new treatments

3 Evaluation of drug candidature: In silico ADMET, binding interactions with CDK7 and normal cell line studies of potentially anti-breast cancer enamidines.

4 Design, synthesis and anticancer activity of new thiazole-tetrazole or triazole hybrid glycosides targeting CDK-2 via structure-based virtual screening

5 CDK promotes interactions of Sld3 and Drc1 with Cut5 for initiation of DNA replication in fission yeast.

6 MicroRNA-129 Inhibits Glioma Cell Growth by Targeting CDK4, CDK6, and MDM2.

7 Natural Aristolactams and Aporphine Alkaloids as Inhibitors of CDK1/Cyclin B and DYRK1A

8 HP-CagA+ Regulates the Expression of CDK4/CyclinD1 via to Change Cell Cycle and Promote Cell Proliferation.

9 Inhibition of colon cancer cell proliferation by the dietary compound conjugated linoleic acid is mediated by the CDK inhibitor p21CIP1/WAF1

10 Ablation of Gsa impairs renal tubule proliferation after injury via CDK2/Cyclin E.

11 A kinome-wide screen identifies a CDKL5-SOX9 regulatory axis in epithelial cell death and kidney injury.

12 Palbociclib and beyond for the treatment of HR + HER2- metastatic breast cancer: An Asian-Pacific perspective and practical management guide on the use of CDK4/6 inhibitors.

13 Abnormal Mitochondria in a Non-human Primate Model of MPTP-induced Parkinson's Disease: Drp1 and CDK5/p25 Signaling

14 amyloid β1-42 (aβ1-42) induces the cdk2-mediated phosphorylation of tau through the activation of the mtorc1 signaling pathway while promoting neuronal cell death

15 early onset primary hyperparathyroidism associated with a novel germline mutation in cdkn1b

16 activation of ampk attenuated cardiac fibrosis by inhibiting cdk2 via p21/p27 and mir-29 family pathways in rats

17 controlling dna-end resection: a new task for cdks

18 long and short-term cdk5 knockdown prevents spatial memory dysfunction and tau pathology of triple transgenic alzheimer´s mice

19 physiological and pathological phosphorylation of tau by cdk5

20 systemic control of cell division and endoreduplication by naa and bap by modulating cdks in root tip cells of allium cepa

21 cdk5r1 overexpression induces primary β-cell proliferation

22 cdk4/6 inhibitor pd0332991 in glioblastoma treatment: does it have a future?

23 selective cdk7 inhibition with bs-181 suppresses cell proliferation and induces cell cycle arrest and apoptosis in gastric cancer

24 the important tumor suppressor role of per1 in regulating the cyclin–cdk–cki network in scc15 human oral squamous cell carcinoma cells

25 molecular mechanism of enhanced anticancer effect of nanoparticle formulated ly2835219 via p16-cdk4/6-prb pathway in colorectal carcinoma cell line

26 RINGO/cdk1 and CPEB mediate poly(A) tail stabilization and translational regulation by ePAB

27 A high-sensitivity phospho-switch triggered by Cdk1 governs chromosome morphogenesis during cell division

28 RINGO/cdk1 and CPEB mediate poly(A) tail stabilization and translational regulation by ePAB

29 Senescence bypass screen identifies TBX2, which represses Cdkn2a (p19(ARF)) and is amplified in a subset of human breast cancers

30 The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2

31 Cdkn2a encodes functional variation of p16INK4a but not p19ARF, which confers selection in mouse lung tumorigenesis

32 RINGO/cdk1 and CPEB mediate poly(A) tail stabilization and translational regulation by ePAB

33 Cdk1-Clb4 controls the interaction of astral microtubule plus ends with subdomains of the daughter cell cortex

34 CDK1 and calcineurin regulate Maskin association with eIF4E and translational control of cell cycle progression

35 Prognostic Impact of Caspase-8, CDK9 and Phospho-CDK9 (Thr 186) Expression in Patients with Uterine Cervical Cancer Treated with Definitive Chemoradiation and Brachytherapy.

36 The non-apoptotic function of Caspase-8 in negatively regulating the CDK9-mediated Ser2 phosphorylation of RNA polymerase II in cervical cancer.

37 Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy

38 Shared Decision-Making on Using a CDK4/6 Inhibitor plus an Aromatase Inhibitor for HR+/HER2- Metastatic Breast Cancer: A Podcast.

39 Association of ADME gene polymorphisms on toxicity to CDK4/6 inhibitors in patients with HR+ HER2- metastatic breast cancer.

40 Eperisone Analogs, Rescuers of MiaB Defects As a Prokaryotic Homologue of CDKAL1, Suppress Blood Glucose Elevation in Rats

41 The effect of dose reduction of CDK4/6 inhibitors on survival in postmenopausal HR+ HER2-negative metastatic breast cancer.